株式会社極東書店トップ商品一覧Melatonin: Therapeutic Value and Neuroprotection.

商品詳細

Melatonin: Therapeutic Value and Neuroprotection.

Melatonin: Therapeutic Value and Neuroprotection.

・ISBN 978-1-4822-2009-4 hard GB£ 260.00

¥82,368.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 9780429174452
著者・編者Srinivasan, Venkatramanujan / Gobbi, Gabriella / Shillcutt, Samuel D. / Suzen, Sibel (eds.),
出版社 (CRC Press Inc, US)
出版年月2014
ページ数574 pp.
言語ENG
ニュース番号<A01-74804>

解説

There is growing interest in the field of melatonin research regarding its neurobiological mechanisms as well as its repercussions in clinical practice. Melatonin: Therapeutic Value and Neuroprotection explores melatonin's neuroprotective effects and discusses the therapeutic potential of melatonin and melatonin agonists in treating neurodegenerative diseases and other ailments. Topics include:



  • The basic aspects of melatonin's physiology, including its production, bioavailability, and metabolism




  • The functional importance of melatonin receptors and their role in mediating the therapeutic effectiveness of melatonin in cancer




  • Melatonin's effect on the regulation of blood pressure, sleep, and circadian rhythms




  • The cardioprotective role of melatonin




  • The neuroprotective role in glaucoma, Alzheimer's disease, Parkinson's disease, and neurodegenerative diseases




  • Use as a therapeutic agent for treating epilepsy and degenerative discs




  • Treatment for obesity, diabetes mellitus, and other metabolic disorders




  • Protective role in peri-natal hypoxic-ischemia


The contributors also examine the discovery of a number of melatonergic agonists, their potential role as antioxidants, and their therapeutic applications in treating glaucoma, Parkinson's disease, Alzheimer's disease, primary insomnia, and psychiatric disorders. Opening new vistas in our understanding of etiology, pharmacotherapy, and treatment, the book is a significant milestone in our knowledge about advances in melatonin's physiology and its therapeutic application in a number of disorders.